Updated Jul 16, 2026
Zohar Daphne has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Daphne Zohar is a business executive known for her role in the biotechnology and pharmaceutical sectors. She is the founder and CEO of Seaport Therapeutics, Inc., a company focused on developing innovative therapies. Zohar has a background in science and business, which she leverages to drive advancements in healthcare.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Daphne Zohar is a business executive known for her role in the biotechnology and pharmaceutical sectors. She is the founder and CEO of Seaport Therapeutics, Inc., a company focused on developing innovative therapies. Zohar has a background in science and business, which she leverages to drive advancements in healthcare.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Zohar Daphne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.